ClinicalTrialsFinder

Hormone Receptor-Positive Breast Cancer Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

Hormone Receptor-Positive Breast CancerHigh-risk Breast Cancer
Peking University People's Hospital393 enrolled1 locationNCT06970912